The Heart Pump Devices Market is a rapidly growing segment within the global cardiovascular medical devices industry, driven by the increasing prevalence of heart failure and advancements in life-saving cardiac technologies. Heart pump devices, also known as mechanical circulatory support devices, are designed to assist or replace the heart’s pumping function in patients suffering from severe cardiac conditions.
The global heart pump devices market has experienced significant growth in recent years and is expected to continue expanding at a strong pace. The market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 6.39 billion by 2030, growing at a compound annual growth rate (CAGR) of about 13.6% . This growth is primarily driven by the rising incidence of cardiovascular diseases, increasing geriatric population, and growing demand for advanced treatment options.
One of the major drivers of the market is the increasing prevalence of heart failure and related disorders such as coronary artery disease and hypertension. Lifestyle changes, including poor diet, lack of physical activity, and rising stress levels, have contributed to a surge in cardiac conditions worldwide. As a result, there is a growing need for effective solutions that can support heart function, especially for patients awaiting heart transplants or those who are not eligible for transplantation.
Technological advancements are playing a crucial role in shaping the heart pump devices market. Modern devices, such as ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO) systems, are becoming more efficient, compact, and durable. Among these, ventricular assist devices dominate the market, accounting for over 68% of the total share due to their effectiveness in supporting long-term cardiac function . These devices are widely used as bridge-to-transplant solutions and increasingly as destination therapy for patients with end-stage heart failure.
Sign up